Monday, October 23, 2017
Tailwinds' Take: a great new hire for the Company, Farr has the experience to help build Tru Niagen into a global consumer brand. His leaving a large global business like Mattel to join CDXC demonstrates the upside potential here. IRVINE,...
Tailwinds' Take: very positive news for CDXC as this demonstrates the positive effects of Niagen in anti-aging activity. Expect more studies to continue showing efficacy and Niagen to become the next blockbuster supplement in the market. IRVINE, Calif., Sept. 26,...
As an investor in ChromaDex (CDXC), and a user of their lead product Tru Niagen, I'm a firm believer in the health benefits of Nicotinamide Riboside (NR). NR in its consumer form is more commonly known as Niagen, which is...
Tailwinds' Take: Watsons is a great partner. The Asian market is the largest for sales of supplements and Tru Niagen is poised to be a very big commercial success overseas. This is the first step towards massive growth for...
Tailwinds' Take: this completes the strategic financing. Li Ka-shing owns a chain of pharmacies and has incredible reach into Asia, including China. As such, the Company's retail product, Tru Niagen, is poised to see incredible growth. Expected news, but...
Company Reports Revenue of $5.3 Million for Q2 2017-  Continued Progress on Building a Consumer Products Platform Around TruNiagen®- IRVINE, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (CDXC), an innovator of proprietary health, wellness and nutritional ingredients,...
IRVINE, Calif., June 27, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that it has appointed...
This morning we have added Chromadex to the Tailwinds Select Portfolio at a price of $3.91. Chromadex holds the worldwide rights to Niagen, a member of the vitamin B-3 family that helps promote healthier living and longer lives. CDXC...
IRVINE, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that it has signed...
IRVINE, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that Charles Brenner, PhD, the...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address